Načítá se...
Development of an ELISA assay for the quantification of soluble huntingtin in human blood cells
BACKGROUND: Huntington’s disease (HD) is a monogenic disorder caused by an aberrant expansion of CAG repeats in the huntingtin gene (HTT). Pathogenesis is associated with expression of the mutant (mHTT) protein in the CNS, with its levels most likely related to disease progression and symptom severi...
Uloženo v:
| Vydáno v: | BMC Biochem |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4221641/ https://ncbi.nlm.nih.gov/pubmed/24274906 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2091-14-34 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|